# TCP10L

## Overview
TCP10L is a human gene that encodes the t-complex 10 like protein, which is characterized by a leucine zipper motif, classifying it as a transcription factor. This protein plays a crucial role in transcription inhibition, primarily through its ability to bind DNA and regulate gene expression. The leucine zipper motif is essential for its function, facilitating dimerization and DNA binding, which are critical for its role as a transcription inhibitor (Chen2003Identification). TCP10L is predominantly expressed in the liver and testis, suggesting a specialized function in these tissues, potentially influencing metabolic processes and development (Chen2003Identification). The protein's nuclear localization further supports its involvement in transcription regulation (Chen2003Identification). While the clinical significance of TCP10L is not fully established, it has been implicated in liver and colorectal cancers, indicating a potential role in tumor suppression and liver function (Chen2003Identification; Yeon2017Frameshift).

## Structure
The TCP10L protein is characterized by a primary structure consisting of 215 amino acids, with a predicted molecular mass of 52 kDa and an acidic isoelectric point of 5.13 (Chen2003Identification). A notable feature of its secondary structure is the presence of a leucine zipper motif, which spans 25 amino acids and includes four periodic repeats of leucine residues. This motif is predicted to adopt a coiled coil conformation, which is crucial for protein-protein interactions and dimerization (Chen2003Identification). The leucine zipper is essential for the protein's function as it facilitates dimerization and DNA binding, playing a significant role in transcription inhibition (Chen2003Identification).

Mutations in the leucine zipper, such as substituting leucine with phenylalanine or arginine, result in a loss of inhibitory activity, underscoring the importance of this structural motif (Chen2003Identification). The protein localizes in the nucleus, supporting its role as a transcription factor (Chen2003Identification). The genomic structure of TCP10L includes five exons and four introns, and it is abundantly expressed in the liver and testis (Chen2003Identification). The context does not provide specific information on the tertiary or quaternary structures, post-translational modifications, or splice variant isoforms.

## Function
The TCP10L gene encodes a human leucine zipper protein that functions as a transcription inhibitor, suggesting its role as a transcription factor. This protein is characterized by a leucine zipper motif, which is crucial for DNA recognition and binding, enabling it to regulate gene expression by inhibiting transcription (Chen2003Identification). TCP10L is predominantly expressed in the liver and testis, indicating a specific function in these organs, potentially influencing metabolic reactions such as synthesis and detoxification in the liver (Chen2003Identification).

Subcellular localization studies have shown that TCP10L accumulates in the nuclei of cells, supporting its role in transcription regulation (Chen2003Identification). The protein's transcription inhibition activity has been demonstrated in various cell lines, with a more pronounced effect in SK-HEP-1 cells, a hepatoma-derived cell line. This inhibition is dose-dependent, and mutations in the leucine zipper motif result in a loss of inhibitory activity, highlighting the importance of this structure for TCP10L's function (Chen2003Identification). The gene's expression pattern and functional characteristics suggest that TCP10L may play a role in the development and physiological functions of the liver, potentially affecting the expression of other genes and liver functions (Chen2003Identification).

## Clinical Significance
The clinical significance of the TCP10L gene is not fully established, but research suggests potential implications in liver and colorectal cancers. TCP10L is specifically expressed in the liver and testis and encodes a leucine zipper protein with transcription inhibition activity, indicating a possible role in liver development and function. Altered expression of TCP10L has been observed in hepatoma tissues, where it is downregulated compared to adjacent non-tumor tissues, suggesting a potential involvement in liver cancer, particularly hepatocellular carcinoma (Chen2003Identification).

In colorectal cancers, TCP10L is considered a tumor suppressor gene. However, a study investigating frameshift mutations in colorectal cancers with high microsatellite instability (MSI-H) found no frameshift mutations in TCP10L among the 79 MSI-H cases analyzed. This suggests that while TCP10L may have a role in tumor suppression, its involvement in colorectal cancer may not be linked to frameshift mutations (Yeon2017Frameshift).

Overall, while TCP10L's role in cancer is suggested, specific mutations or expression alterations directly linked to clinical outcomes remain to be fully elucidated. Further research is needed to clarify its clinical significance in these and potentially other conditions.


## References


[1. (Chen2003Identification) Zheng Chen, Long Yu, Hai Wu, Jianqiang Yu, Lisha Zhang, Daojun Jiang, Lijie Ma, Dan Li, and Shouyuan Zhao. Identification of a novel liver-specific expressed gene, tcp10l, encoding a human leucine zipper protein with transcription inhibition activity. Journal of Human Genetics, 48(11):556–563, October 2003. URL: http://dx.doi.org/10.1007/s10038-003-0075-6, doi:10.1007/s10038-003-0075-6. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10038-003-0075-6)

[2. (Yeon2017Frameshift) Su Yeon Yeon, Yun Sol Jo, Eun Ji Choi, Min Sung Kim, Nam Jin Yoo, and Sug Hyung Lee. Frameshift mutations in repeat sequences of ank3, hacd4, tcp10l, tp53bp1, mfn1, lcmt2, rnmt, trmt6, mettl8 and mettl16 genes in colon cancers. Pathology &amp; Oncology Research, 24(3):617–622, August 2017. URL: http://dx.doi.org/10.1007/s12253-017-0287-2, doi:10.1007/s12253-017-0287-2. This article has 42 citations.](https://doi.org/10.1007/s12253-017-0287-2)